National Academies Press: OpenBook
« Previous: Appendix A: Reprint of the commitee's November 2000 Interim Report, Urgent Attention Needed to Restore Lapsed Adenovirus Vaccine Availability: A Letter Report,
Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×

Appendix B
Open Meeting Agendas

Meeting I

April 3 and 4, 2000

The Foundry Building, Washington, D.C.

3 April 2000

10:00AM

Sponsor Presentation: Charge to the IOM and Welcoming Remarks

MG John S. Parker, M.D.,

Commanding General

U.S. Army Medical Research and Materiel Command

 

Overview of the Military Infectious Diseases Research Program

COL Charles H. Hoke, Jr., M.D.,

Research Area Director

Military Infectious Diseases Research Program

11:00AM

Break

11:15AM

Sponsor Presentation, continued

Overview of the DoD Research and Development (Acquisition) Model

COL Rodney A. Michael, M.D.

Research Area Deputy Director

Military Infectious Diseases Research Program

Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×

 

Biologic Warfare Defense Research and Endemic Infectious Diseases

Research: Whence and why the dichotomy

COL John F. Glenn, Ph.D.

Deputy for Research and Development

U.S. Army Medical Research and Materiel Command

12:15PM

Lunch

1:15PM

Discussion with Sponsor:

Current challenges

Overview of the challenges to adequate vaccine strategy presented by industry and DoD policies and constraints

Overview of the regulatory parameters that currently affect military vaccine strategy

Discussion of what the U.S. Army seeks to gain from this committee report

Discussion of charge

2:15PM

Break, end of open session

Meeting II

June 19 and 20, 2000

The Foundry Building, Washington, D.C.

19 June 2000

10:00AM

Welcome and Introduction

Stanley Lemon, M.D., Chair

10:05AM

Examples of the Impact of Vaccine Preventable Infectious Disease:

 

Impact of Recent Adenovirus Outbreaks in Military Training Centers

CAPT Gregory Gray, M.D., M.P.H.

Director, DoD Center for Deployment Health Research

Naval Health Research Center, San Diego

 

Lt Col James Neville, M.D., M.P.H.

Chief, Force Health Protection and Surveillance Branch

U.S. Air Force Institute for Environment, Safety & Occupational

Health Risk Analysis

Brooks Air Force Base

Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×

 

Leonard N. Binn, Ph.D.

Supervisory Research Microbiologist, Department of Virus Diseases

Walter Reed Army Institute of Research

 

The Meningococcal Meningitis Situation, Military and Civilian

Juliette Morgan, M.D.

Medical Epidemiologist, Meningitis and Special Pathogens Branch

Centers for Disease Control and Prevention

 

John Brundage, M.D., M.P.H.

Senior Research Epidemiologist, Henry M. Jackson Foundation

Army Medical Surveillance Activity

Walter Reed Army Institute of Research

11:30AM

JVAP—Procurement Process for Vaccines for Biowarfare Defense

Richard B. Paul, M.A.

Acting Program Manager, Joint Vaccine Acquisition Program

12:00PM

Vaccine Development Success–Policy Failure

Adenovirus Vaccine: Successful Development

Franklin H. Top, Jr., M.D.

Executive Vice President and Medical Director, MedImmune

 

Adenovirus Vaccine: A Policy Failure

Joel Gaydos, M.D., M.P.H.

DoD Global Emerging Infections Surveillance & Response System,

Division of Preventive Medicine, Walter Reed Army Institute of Research

12:45PM

Lunch (and continued discussion)

1:30PM

Vaccine Research & Development: Priority Setting

DoD Requirements Generation and Acquisition

James H. Nelson, Ph.D.

Director, U.S. Army Medical Materiel Development Activity

 

Military Medical Surveillance of Infectious Disease

LTC Mark V. Rubertone, M.D., M.P.H.

Chief, Army Medical Surveillance Activity

U.S. Army Center for Health Promotion and Preventive Medicine

Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×

 

Medical Intelligence

Deborah G. Keimig, Ph.D.

Chief, Epidemiology and Environmental Health Division

Armed Forces Medical Intelligence Center, Fort Detrick

 

Priority Setting in Practice

COL Rodney A. Michael, M.D.

Deputy Director, Military Infectious Disease Research Program

 

Discussion

4:00PM

Open session ends

20 June 2000

7:30AM

Continental Breakfast

8:00AM

Review of Meeting Day 1 and Introduction of Day 2 Program

Stanley Lemon, M.D., Chair

8:20AM

Status of Limited Use Vaccines in the Military

LTC Phillip R. Pittman, M.D., M.P.H.

Senior Medical Scientist

U.S. Army Research Institute of Infectious Diseases

8:50AM

How Others (Try to) Make Limited Use Vaccine Development Work:

 

Food and Drug Administration

Karen Goldenthal, M.D.

Director, Division of Vaccines & Related Products Applications

 

National Institute of Allergy and Infectious Disease, National Institutes of Health

Carole A. Heilman, Ph.D.

Director, Division of Microbiology and Infectious Diseases

 

Centers for Disease Control and Prevention

James W. LeDuc, Ph.D.

Acting Director, Division of Viral and Rickettsial Diseases

National Center for Infectious Diseases

Centers for Disease Control and Prevention

Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×

 

Industry Involvement in Federal Vaccine Development and Procurement Efforts

Thomas P. Monath, M.D.

Vice President, Research & Medical Affairs, OraVax Inc.

 

Discussion: Constraints Faced and Handled

How Might DoD Use These Approaches

11:45AM

Lunch—with concurrent discussion based on morning’s presentations

Open session ends

Meeting III

September 21 and 22, 2000

The Foundry Building, Washington, D.C.

21 September 2000

11:00AM

Welcome

Stanley Lemon, M.D., Chair

11:05AM

Adenovirus vaccine

MAJ Michael Dyer, M.S.

Office of the TRADOC Surgeon

William Howell

Deputy for Acquisition and Advanced Development

U.S. Army Medical Research and Materiel Command

12:00PM

Lunch

12:45PM

Vaccine production

Gary Nabel, M.D., Ph.D.

Director, NIH Vaccine Research Center

Jack Melling, Ph.D.

formerly with the Salk Institute and the Center for Applied Microbiology and Research

2:00PM

Priorities

LTC Brian G. Scott, M.D.

Clinical Consultant, Force Protection AMEDD Center and School

Directorate of Combat and Doctrine Development

Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×

 

COL John Frazier Glenn, Ph.D.

Deputy for Research and Development

U.S. Army Medical Research and Materiel Command

 

Discussion

Presenters along with:

COL Charles Hoke, Jr., M.D.

COL Rodney Michael, M.D.

4:00PM

Discussion

5:00PM

Adjourn for the day

Meeting IV

November 13 and 14, 2000

The Foundry Building, Washington, D.C.

13 November 2000

9:30AM

Continental breakfast in conference room

10:00AM

Review agenda, introduce speakers

10:10AM

Incentivizing limited use vaccine production: getting and keeping vaccines

Kevin L. Reilly

President, Wyeth Vaccines, Wyeth Pharmaceuticals

11:30AM

Public release of this committee’s interim report:

Urgent Attention Needed to Restore Lapsed Adenovirus Vaccine

Availability: A Letter Report

Stanley Lemon, M.D., Chair

 

Adenovirus update

CDR Jeff Yund, M.D.

Division of Preventive Medicine and Occupational Health

U.S. Navy Bureau of Medicine and Surgery

12:30PM

Working lunch in conference room for committee, staff, and guests

1:30PM

Priority setting revisited (panel discussion)

COL John Frazier Glenn, Ph.D.

Deputy for Research and Development

U.S. Army Medical Research and Materiel Command

Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×

 

LTC Brian G. Scott, M.D.

Clinical Consultant, Force Protection

Directorate of Combat and Doctrine Development

AMEDD Center & School

 

COL Charles Hoke, Jr., M.D.

Director, Military Infectious Diseases Research Program

U.S. Army Medical Research and Materiel Command

3:00PM

Open session ends

Meeting V

Tuesday, February 27, 2001

The Foundry Building, Washington, D.C.

12:00PM

Working lunch in conference room for committee, staff, and guests

1:00PM

Setting vaccine priorities in DoD

Anna Johnson-Winegar, Ph.D.

Deputy Assistant to the Secretary of Defense

Counterproliferation and Chemical/Biological Defense

2:00PM

Open session ends

Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×
This page in the original is blank.
Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×
Page 119
Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×
Page 120
Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×
Page 121
Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×
Page 122
Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×
Page 123
Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×
Page 124
Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×
Page 125
Suggested Citation:"Appendix B: Open Meeting Agendas." Institute of Medicine. 2002. Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military. Washington, DC: The National Academies Press. doi: 10.17226/10483.
×
Page 126
Next: Appendix C: Committee and Staff Biographies »
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military Get This Book
×
Buy Paperback | $42.00 Buy Ebook | $33.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Infectious diseases continue to pose a substantial threat to the operational capacity of military forces. Protecting Our Forces reviews the process by which the U.S. military acquires vaccines to protect its warfighters from natural infectious disease threats. The committee found that poorly aligned acquisition processes and an inadequate commitment of financial resources within the Department of Defense vaccine acquisition process – rather than uncleared scientific or technological hurdles – contribute to the unavailability of some vaccines that could protect military personnel and, implicitly, the welfare and security of the nation. Protecting Our Forces outlines ways in which DoD might strengthen its acquisition process and improve vaccine availability. Recommendations, which include combining all DoD vaccine acquisition responsibilities under a single DoD authority, cover four broad aspects of the acquisition process: (1) organization, authority, and responsibility; (2) program and budget; (3)manufacturing; (4) and the regulatory status of special-use vaccines.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!